On the contrary, and to our surprise, the NEPAL signature exhibited exciting power in predicting not only prognosis, such as BCR and OS, but also resistance to hormonal therapy and chemotherapy in more than 10 human PCa datasets. This evidence concerns the gene BCR and posterior cortical atrophy.